Michael Berg
Direttore Tecnico/Scientifico/R&S presso TEARLAB CORPORATION
Profilo
Michael Berg is currently the Head-Regulatory, Reimbursement & Clinical at TearLab Corporation, Inc. and the President at Hemocue, Inc. He completed his undergraduate degree at the University of Notre Dame.
Posizioni attive di Michael Berg
| Società | Posizione | Inizio |
|---|---|---|
| TEARLAB CORPORATION | Direttore Tecnico/Scientifico/R&S | - |
| Hemocue, Inc. | Presidente | 20/05/2010 |
Formazione di Michael Berg
| University of Notre Dame | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
| Hemocue, Inc. |
- Borsa valori
- Insiders
- Michael Berg
